App

• The FDA has approved the first mRNA-based influenza vaccine, reversing a previous decision earlier this year to decline the application's review. • The approval covers adults aged 50 to 64, while those aged 65 and older have received accelerated approval. • This decision follows a large-scale clinical trial that yielded largely favorable results, despite an unusual initial rejection by the agency.

• Prime Minister Anthony Albanese has signaled a willingness to take action against gambling advertisement inducements to secure legislative progress. • This strategic move is designed to win the support of the Coalition for the government's proposed gambling law reforms. • The initiative matters as it addresses the controversial use of incentives in gambling ads, which has been a point of contention in federal policy.

Scharf, who helped president win approval for $400m ballroom, to replace David Warrington on 1 SeptemberDonald Trump announced on Sunday that ⁠Will ​Scharf, the staff secretary who helped secure approval for the $400m White House ballroom project, will become ⁠White House counsel and assistant to the president.Effective 1 September, Scharf will replace David Warrington, who will be leaving the administration to join the private sector. Warrington ​formerly served ​as a ​personal counsel and a ​lawyer ‌for Trump’s ​2024 campaign. Continue reading...

• The FDA has authorized Moderna’s mFlusiva, marking the first mRNA-based flu vaccine approved for use in older adults. • Separately, U.S. health officials are reviewing the nation's measles elimination status following 38 new outbreaks in 2026. • In a legal ruling, a judge designated Meta’s platforms as a "public nuisance," ordering the company to fund mental health remediation efforts.

• The FDA has approved a new engineered viral immunotherapy designed specifically for patients suffering from treatment-resistant advanced melanoma. • This approval provides a critical new therapeutic option for cancer patients who have failed to respond to existing standard-of-care treatments. • The authorization is granted under conditions where continued market availability may be contingent upon the verification of clinical benefits.

• The FDA has approved the first-of-its-kind mRNA-based flu vaccine specifically for adults aged 50 and older. • This approval follows a severe 2024-25 flu season, which the CDC estimates resulted in approximately 45,000 deaths. • The shift to mRNA technology is significant as it offers the potential for more effective, rapidly adaptable vaccines compared to traditional methods.

Exclusive: Workers’ rights experts raise ‘alarm bells’ over app requiring ABNs for jobs they say lack worker autonomyGet our breaking news email, free app or daily news podcastConcerns have been raised that workers using an increasingly popular Australian hospitality gig-work app may be missing out on entitlements such as superannuation by being hired as “independent contractors”, similar to delivery riders.Launched in Melbourne in 2017, Supp describes itself as a “jobs marketplace”, where hospitality businesses can advertise available shifts to potential workers at an hourly rate, and where workers can secure ad-hoc employment. It was created by Kate and Cameron Reid, the owners of Lune Croissanterie, who maintain a financial stake in the company but are no longer on its board. Continue reading...

• The FDA has approved mFlusiva, marking the first time an mRNA-based vaccine has been authorized for the prevention of influenza. • Unlike traditional flu vaccines, mRNA technology allows manufacturers to produce shots more rapidly, reducing the likelihood of a mismatch between the vaccine and circulating strains. • Medical experts, including Dr. Paul Pottinger of UW Medical Center, describe the approval as a significant advancement in public health.